Planned IPO

Thomas Straumann, founder and Chairman of Medartis: “The planned IPO will mark an important milestone in the development of Medartis and will allow us to take the company to the next level. There are numerous opportunities for us to grow, and the timing is right for us to offer shares and seek a listing, in order to be in a strong position to capture these favorable prospects. I am extremely proud of what Medartis and our employees have achieved since our founding just over 20 years ago. Our focus on providing customers around the world with innovative, high-quality, Swiss-made fixation system solutions, combined with continuous support and education, has been the cornerstone of our success.” 

Willi Miesch, CEO of Medartis: “Over the last 20 years, we have managed to build a company with a unique portfolio of implant systems combined with deep relationships with our customers, who we highly value. With the planned IPO, we can continue to invest in these relationships, in developing new ones, and in expanding further into untapped geographies and additional indications. We have a pipeline of new systems which we will introduce over the course of 2018, 2019 and beyond. With our focus on optimal treatment solutions, providing users with regular and high-quality continuing education, and commitment to best-in-class services, I believe we have ample opportunities ahead to grow our business.”  

Read the unshortended press release: